Metraipolis › archive › dc_745747ef948e

Retrospective Study of Severe Atopic Disease in Young Children (0-5 Years) Managed with Dupilumab Highlights Significant Comorbidities — Europe PMC PMID:41462779

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41462779
DOI
10.3390/children12121639
License (as archived)
solo-consultazione
Archived
2026-11-08T00:49:33.993Z
SHA-256 of the archived text
82a211440367c950216464ee8dbf2c9b5b13cb1d6f147bf7a4323cfb77855891
Stable URL of this page
https://metraipolis.com/documento/dc_745747ef948e

How to cite

Retrospective Study of Severe Atopic Disease in Young Children (0-5 Years) Managed with Dupilumab Highlights Significant Comorbidities — Europe PMC PMID:41462779 — Europe PMC (en), https://europepmc.org/article/MED/41462779 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_745747ef948e (Metraipolis archive dc_745747ef948e, sha256 82a211440367c950216464ee8dbf2c9b5b13cb1d6f147bf7a4323cfb77855891)
BibTeX
@misc{dc745747ef948e,
  title = {Retrospective Study of Severe Atopic Disease in Young Children (0-5 Years) Managed with Dupilumab Highlights Significant Comorbidities — Europe PMC PMID:41462779},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41462779},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_745747ef948e; sha256 82a211440367c950216464ee8dbf2c9b5b13cb1d6f147bf7a4323cfb77855891},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41462779. Agents can read the archived copy with the MCP tool read_document.